🔎 Trials Near Me

Dachaigh › Galaran nan Sgamhan › Tennessee

Sgrùdaidhean clionaigeach Galaran nan Sgamhan ann an Tennessee

Tha 15 sgrùdaidhean airson Galaran nan Sgamhan a’ lorg phàirtichean aig làraichean ann an Tennessee.

Bailtean ann an Tennessee

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Premier Research Center, LLC, Hendersonville
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06977581

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • SCRI Oncology Partners, Nashville
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06765109

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • West Tennessee Research Institute, Jackson
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07013474

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • WR-Clinsearch, LLC, Chattanooga
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06679140

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

  • University of Tennessee Medical Center, Knoxville
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07489066

American Lung Association (ALA) Lung Health Cohort

  • Vanderbilt University Medical Center, Nashville
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 25 gu 35 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Sarah Cannon Research Institue, Nashville
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Tennessee Oncology Chattanooga, Chattanooga
  • University of Tennessee Medical Center, Knoxville
  • Baptist Memorial Hospital-Memphis, Memphis
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06119581

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Vanderbilt University Medical Center, Nashville
A’ fastadhÌre 2
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07059091

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Clinical Trials Center of Middle Tennesee LLC, Franklin
A’ fastadhÌre 3
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07284602

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  • SCRI Oncology Partners, Nashville
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT05967689

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Vanderbilt University Medical Center, Nashville
A’ fastadhSgrùdadh amharc
Aoisean 4 gu 65 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05153967

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • University of Tennessee Medical Center, Knoxville
  • Baptist Cancer Center, Memphis
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT04614103

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT03093116

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Tristar Bone Marrow Transplant, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Dùbh 2025 · NCT06619561

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.